We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
NECLIFE.NSE

Price
21.88
Stock movement down
-0.79 (-3.48%)
Company name
Nectar Lifesciences Limited
Exchange
(NSE
,
Currency
INR
)
Sector
Healthcare >
Drug Manufacturers - Specialty & Generic
Market cap
4.91B
Ent value
15.78B
Price/Sales
0.29
Price/Book
0.46
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
45.74
Forward P/E
-
PEG
-
EPS growth
-36.45%
1 year return
-38.28%
3 year return
-3.83%
5 year return
22.44%
10 year return
-4.26%
Last updated: 2025-04-12

DIVIDENDS

NECLIFE.NSE does not pay dividends or no data was received

VALUATION

Valuation Ratios

Valuation Ratios data
Trailing P/E45.74
Price to OCF15.96
Price to FCF15.96
Price to EBITDA11.63
EV to EBITDA37.40

Valuation (Sales/Book Value)

Valuation (Sales/Book Value) data
Price to Sales0.29
Price to Book0.46
EV to Sales0.94

FINANCIALS

Per share

Per share data
Current share count224.26M
EPS (TTM)0.48
FCF per share (TTM)1.37

Income statement

Income statement data
Revenue (TTM)16.81B
Gross profit (TTM)3.97B
Operating income (TTM)849.63M
Net income (TTM)107.27M
EPS (TTM)0.48
EPS (1y forward)-

Margins

Margins data
Gross margin (TTM)23.62%
Operating margin (TTM)5.06%
Profit margin (TTM)0.64%

Balance Sheet

Please create a free account or log in to access this chart
Balance Sheet data
Cash182.40M
Net receivables0.00
Total current assets13.05B
Goodwill0.00
Intangible assets507.40M
Property, plant and equipment0.00
Total assets21.83B
Accounts payable4.13B
Short/Current long term debt6.29B
Total current liabilities9.97B
Total liabilities11.05B
Shareholder's equity10.78B
Net tangible assets0.00

Cash flow

Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)307.47M
Capital expenditures (TTM)0.00
Free cash flow (TTM)307.47M
Dividends paid (TTM)0.00

Financial returns

Please create a free account or log in to access this chart
Financial returns data
Return on Equity1.00%
Return on Assets0.49%
Return on Invested Capital0.67%
Cash Return on Invested Capital1.91%

STOCK INFORMATION

Stock chart

Stock price data
Open23.30
Daily high23.30
Daily low20.99
Daily Volume1.42M
All-time high60.35
1y analyst estimate42.00
Beta1.03
EPS (TTM)0.48
Dividend per share-
Ex-div date18 Sep 2020
Next earnings date13 May 2025

Downside potential

Downside potential data
NECLIFE.NSES&P500
Current price drop from All-time high-63.74%-12.89%
Highest price drop-87.66%-56.47%
Date of highest drop23 Mar 20209 Mar 2009
Avg drop from high-44.62%-11.07%
Avg time to new high163 days12 days
Max time to new high2320 days1805 days
COMPANY DETAILS
NECLIFE.NSE (Nectar Lifesciences Limited) company logo
Marketcap
4.91B
Marketcap category
Mid-cap
Description
Nectar Lifesciences Limited manufactures and sells pharmaceutical products in India and internationally. The company's active pharmaceutical ingredients and intermediates comprise cefixime, cefuroxime axetil amorphous, cefuroxime axetil crystalline, cefotaxime sodium, ceftriaxone sodium, cefixime trihydrate, cefuroxime axetil, cefpodoxime proxetil and sterile, cefprozil, cefdinir, cefuroxime sodium, cefazolin sodium, ceftazidime pentahydrate, and cefepime +Arginine. It also offers contract manufacturing for finished dosage forms, such as tablets, capsules, dry powder oral suspensions, and granules and injectable for cephalosporins. In addition, the company provides menthol and pearl capsules. Nectar Lifesciences Limited was incorporated in 1995 and is headquartered in Chandigarh, India.
Employees
1686
Website
https://www.neclife.com
Investor relations
-
SEC filings
NECLIFE.NSE SEC filings
CEO
Country
India
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
UNDERSTAND THE BUSINESS
COMPANY NEWS
All newsPress releases
No items found
Disclaimer
Skyfall Technology OÜ assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness or timeliness. Please also note, that any action you take upon the information provided on this website is strictly at your own risk. This website is intended to be used and must be used for informational purposes only and you should take independent financial advice from a professional and independently research and verify everything you see on the site.
Menu
HomePortfolio ManagementCompany ScreenerGreen InvestmentExchangesContact Us
Language
ENHUNOSVDAFIESDENLFRITPTPLCSSKROELTRRUAF
© 2024 Skyfall Technology OÜ All Rights Reserved